Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2010
11/25/2010WO2010134942A1 Electrostatically charged multi-acting nasal application, product and method
11/25/2010WO2010134384A1 Skin function-improving composition
11/25/2010WO2010133882A1 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
11/25/2010WO2010133672A1 Derivatives of quinoline-3-carboxylic acid and their medical use
11/25/2010WO2010107185A3 Composition for skin regeneration, containing a secretion in the culture of an embryonic stem cell-derived endothelial progenitor cell or fractions thereof, and use thereof
11/25/2010WO2010100650A3 Therapeutic uses of mastic gum fractions
11/25/2010WO2010088050A3 Bicyclic pyrazolo-heterocycles
11/25/2010US20100298758 Method for non-therapeutic or therapeutic photodynamic skin treatment
11/25/2010US20100298528 Cystine knot molecules
11/25/2010US20100298444 Method for improving the therapeutic efficacy of curcuminoids and their analogs
11/25/2010US20100298427 Anti-inflammatory compositions and their use
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298395 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
11/25/2010US20100298383 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
11/25/2010US20100298370 Benzothiazolyl thienopyridine derivatives and uses thereof
11/25/2010US20100298368 Antagonists of pgd2 receptors
11/25/2010US20100298365 Topical administration carrier composition and therapeutic formulations comprising same
11/25/2010US20100298364 salts 756
11/25/2010US20100298361 Alkylthio Pyrimidines As CRTH2 Antagonists
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298334 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
11/25/2010US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors
11/25/2010US20100298314 Novel jnk inhibitors
11/25/2010US20100298307 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
11/25/2010US20100298292 Modulators of 5-ht receptors and methods of use thereof
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298286 Organic Compounds
11/25/2010US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/25/2010US20100298269 Prodrugs of cgrp receptor antagonists
11/25/2010US20100298263 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
11/25/2010US20100298259 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/25/2010US20100298251 Wound-healing agent containing momordicae semen extract
11/25/2010US20100298249 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/25/2010US20100298235 Epithelial cell growth promoter
11/25/2010US20100298232 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
11/25/2010US20100298231 Pmma binding peptides
11/25/2010US20100298220 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010US20100297274 Cocoa extracts for use in providing skin benefits
11/25/2010US20100297273 Emulsified wax compositions and uses thereof
11/25/2010US20100297258 Treatment of burns
11/25/2010US20100297245 Methods and compositions for oral administration of protein and peptide therapeutic agents
11/25/2010US20100297238 Multifunctional and Biologically Active Matrices from Multicomponent Polymeric Solutions
11/25/2010US20100297236 Hybrid inducible release vehicle
11/25/2010US20100297235 Vascular puncture closure systems, devices, and methods using biocompatible synthetic hydrogel compositions
11/25/2010US20100297233 Oscillating cell culture bioreactor
11/25/2010US20100297212 Scaffold for cell growth and differentiation
11/25/2010US20100297208 Scaffold
11/25/2010US20100297156 Analogues of phosphatidylinositol mannosides
11/25/2010US20100297151 Antibodies against human il-21 receptor and uses therefor
11/25/2010US20100297150 Disease treatment via antimicrobial peptide inhibitors
11/25/2010US20100297143 Methods for treating psoriasis
11/25/2010US20100297107 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
11/25/2010US20100297097 Compounds
11/25/2010US20100297095 Porifera-Based Therapeutic Compositions for Treating and Preventing Skin Diseases
11/25/2010US20100297088 Methods for Culturing Minimally-Passaged Fibroblasts and Uses Thereof
11/25/2010US20100297074 Wound healing compositions, systems, and methods
11/25/2010US20100297054 1,2,3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
11/25/2010US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors
11/25/2010US20100297043 Skin coating composition and uses thereof
11/25/2010DE102010007381A1 Prophylaxemittel gegen Krebskrankheiten und erhöhte Hautspannungen Prophylaxis for cancer diseases and increased skin tension
11/25/2010CA2762989A1 Application and uses of prg4 and therapeutic modulation thereof
11/25/2010CA2762770A1 Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
11/25/2010CA2762212A1 Elastin for soft tissue augmentation
11/25/2010CA2761954A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010CA2760765A1 Disaccharin, difumaric acid, di-1-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamino)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin-5-yl) methyl) phenyl)acetate
11/24/2010EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody
11/24/2010EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
11/24/2010EP2253323A1 Anti-allergic agent
11/24/2010EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
11/24/2010EP2252690A2 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
11/24/2010EP2252615A1 Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists
11/24/2010EP2252597A2 Novel compounds, use and preparation thereof
11/24/2010EP2252324A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases
11/24/2010EP2252320A2 Use of anti-connexin polynucleotides and peptides for the treatment of abnormal or excessive scars
11/24/2010EP2252282A2 Cosmetic and/or dermatological composition
11/24/2010EP1910398B1 17-alpha-substituted derivatives of estradiol with wound-healing activity
11/24/2010EP1758588B1 Pharmaceutical composition comprising an ointment and two solubilized active principles
11/24/2010EP1603917B1 Immunomodulating heterocyclic compounds
11/24/2010EP1562585B1 Daily melatonin dosing units
11/24/2010EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/24/2010EP1539739B1 Piperidinyl compounds that selectively bind integrins
11/24/2010EP1502949B1 Antimicrobial polypeptide and utilization thereof
11/24/2010EP1423082B1 Plasma protein matrices and methods for their preparation
11/24/2010EP1385948B1 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
11/24/2010EP1326896B1 Human anti-cd40 antibodies
11/24/2010EP1100454B1 Pharmaceutical compositions for managing skin conditions
11/24/2010CN201642992U Acne removing plaster
11/24/2010CN1970020B A pharmaceutical composition, preparation process and application thereof
11/24/2010CN1942163B Hair restorer
11/24/2010CN1696100B Now short cutting method for synthcsizing Adpalin dryg trcatubg acnc
11/24/2010CN101896595A Bactericidal cleanser composition
11/24/2010CN101896168A Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release
11/24/2010CN101892177A Antifungal lipopeptid-containing skin liniment and preparation method thereof
11/24/2010CN101892176A Microbe generating antifungal lipopeptid and preparation method and application of antifungal lipopeptid thereof
11/24/2010CN101891826A Targeted hIL-10 recombinant protein and application thereof
11/24/2010CN101891738A Dasatinib polymorph and preparation method and medical composite thereof
11/24/2010CN101890166A Combination of organic compounds
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 1065